| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2017-09-09 06:37:18 UTC |
|---|
| Update Date | 2022-11-30 19:26:25 UTC |
|---|
| HMDB ID | HMDB0115985 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | CDP-DG(20:3(8Z,11Z,14Z)/20:3(5Z,8Z,11Z)) |
|---|
| Description | CDP-DG(20:3(8Z,11Z,14Z)/20:3(5Z,8Z,11Z)) is a cytidine diphosphate diacylglycerol or CDP-diacylglycerol (CDP-DG). CDP-diacylglycerol is an important branchpoint intermediate in eukaryotic phospholipid biosynthesis and could be a key regulatory molecule in phospholipid metabolism. It is a glycerophospholipid in which a cytidine diphosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, CDP-diacylglycerols can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. CDP-DG(20:3(8Z,11Z,14Z)/20:3(5Z,8Z,11Z)), in particular, consists of one chain of dihomo-gamma-linolenic acid at the C-1 position and one chain of mead acid at the C-2 position. Cytidine diphosphate diacylglycerols are rarely noticed in analyses of lipid compositions of tissues, as they are present is such small amounts (perhaps only 0.05% or so of the total phospholipids). |
|---|
| Structure | [H][C@@](COC(=O)CCCCCC\C=C/C\C=C/C\C=C/CCCCC)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H](C(O)[C@H]1O)N1C=CC(N)=NC1=O)OC(=O)CCC\C=C/C\C=C/C\C=C/CCCCCCCC InChI=1S/C52H85N3O15P2/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-37-47(56)65-41-44(68-48(57)38-36-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2)42-66-71(61,62)70-72(63,64)67-43-45-49(58)50(59)51(69-45)55-40-39-46(53)54-52(55)60/h11,13,17-20,23-26,30,32,39-40,44-45,49-51,58-59H,3-10,12,14-16,21-22,27-29,31,33-38,41-43H2,1-2H3,(H,61,62)(H,63,64)(H2,53,54,60)/b13-11-,19-17-,20-18-,25-23-,26-24-,32-30-/t44-,45-,49+,50?,51-/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 1-Dihomo-gamma-linolenoyl-2-meadoyl-sn-glycero-3-CDP | HMDB | | 1-Dihomo-gamma-linolenoyl-2-meadoyl-sn-glycero-3-cytidine-5'-diphosphate | HMDB | | CDP-DG(20:3/20:3) | HMDB | | CDP-DG(20:3N6/20:3N9) | HMDB | | CDP-DG(20:3W6/20:3W9) | HMDB | | CDP-DG(40:6) | HMDB | | CDP-Diacylglycerol(20:3(8Z,11Z,14Z)/20:3(5Z,8Z,11Z)) | HMDB | | CDP-Diacylglycerol(20:3/20:3) | HMDB | | CDP-Diacylglycerol(20:3N6/20:3N9) | HMDB | | CDP-Diacylglycerol(20:3W6/20:3W9) | HMDB | | CDP-Diacylglycerol(40:6) | HMDB | | {[(2R,3R,5R)-3,4-dihydroxy-5-(2-hydroxy-4-imino-1,4-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy}({hydroxy[(2R)-2-[(5Z,8Z,11Z)-icosa-5,8,11-trienoyloxy]-3-[(8Z,11Z,14Z)-icosa-8,11,14-trienoyloxy]propoxy]phosphoryl}oxy)phosphinate | HMDB | | 1-dihomo-gamma-linolenoyl-2-meadoyl-sn-glycero-3-CDP | SMPDB, HMDB | | 1-dihomo-gamma-linolenoyl-2-meadoyl-sn-glycero-3-cytidine-5'-diphosphate | SMPDB, HMDB | | CDP-DG(20:3/20:3) | SMPDB, HMDB | | CDP-DG(20:3n6/20:3n9) | SMPDB, HMDB | | CDP-DG(20:3w6/20:3w9) | SMPDB, HMDB | | CDP-DG(40:6) | SMPDB, HMDB | | CDP-diacylglycerol(20:3(8Z,11Z,14Z)/20:3(5Z,8Z,11Z)) | SMPDB, HMDB | | CDP-diacylglycerol(20:3/20:3) | SMPDB, HMDB | | CDP-diacylglycerol(20:3n6/20:3n9) | SMPDB, HMDB | | CDP-diacylglycerol(20:3w6/20:3w9) | SMPDB, HMDB | | CDP-DG(20:3(8Z,11Z,14Z)/20:3(5Z,8Z,11Z)) | SMPDB |
|
|---|
| Chemical Formula | C52H85N3O15P2 |
|---|
| Average Molecular Weight | 1054.206 |
|---|
| Monoisotopic Molecular Weight | 1053.545593045 |
|---|
| IUPAC Name | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-2-[(5Z,8Z,11Z)-icosa-5,8,11-trienoyloxy]-3-[(8Z,11Z,14Z)-icosa-8,11,14-trienoyloxy]propoxy]phosphoryl}oxy)phosphinic acid |
|---|
| Traditional Name | [(2R,3R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy([hydroxy((2R)-2-[(5Z,8Z,11Z)-icosa-5,8,11-trienoyloxy]-3-[(8Z,11Z,14Z)-icosa-8,11,14-trienoyloxy]propoxy)phosphoryl]oxy)phosphinic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H][C@@](COC(=O)CCCCCC\C=C/C\C=C/C\C=C/CCCCC)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H](C(O)[C@H]1O)N1C=CC(N)=NC1=O)OC(=O)CCC\C=C/C\C=C/C\C=C/CCCCCCCC |
|---|
| InChI Identifier | InChI=1S/C52H85N3O15P2/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-37-47(56)65-41-44(68-48(57)38-36-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2)42-66-71(61,62)70-72(63,64)67-43-45-49(58)50(59)51(69-45)55-40-39-46(53)54-52(55)60/h11,13,17-20,23-26,30,32,39-40,44-45,49-51,58-59H,3-10,12,14-16,21-22,27-29,31,33-38,41-43H2,1-2H3,(H,61,62)(H,63,64)(H2,53,54,60)/b13-11-,19-17-,20-18-,25-23-,26-24-,32-30-/t44-,45-,49+,50?,51-/m1/s1 |
|---|
| InChI Key | BBKOQQXKKGFGLJ-QYQJRGRFSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as cdp-diacylglycerols. These are glycerolipids containing a diacylglycerol, with a cytidine diphosphate attached to the oxygen O1 or O2 of the glycerol part. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Glycerophospholipids |
|---|
| Sub Class | CDP-glycerols |
|---|
| Direct Parent | CDP-diacylglycerols |
|---|
| Alternative Parents | |
|---|
| Substituents | - Cdp-diacylglycerol
- Pyrimidine ribonucleoside diphosphate
- Diacyl-glycerol-3-pyrophosphate
- Pentose phosphate
- Pentose-5-phosphate
- Glycosyl compound
- N-glycosyl compound
- Monosaccharide phosphate
- Organic pyrophosphate
- Pentose monosaccharide
- Aminopyrimidine
- Fatty acid ester
- Pyrimidone
- Monoalkyl phosphate
- Imidolactam
- Pyrimidine
- Fatty acyl
- Alkyl phosphate
- Phosphoric acid ester
- Dicarboxylic acid or derivatives
- Hydropyrimidine
- Organic phosphoric acid derivative
- Monosaccharide
- Tetrahydrofuran
- Heteroaromatic compound
- Secondary alcohol
- Amino acid or derivatives
- 1,2-diol
- Carboxylic acid ester
- Organoheterocyclic compound
- Azacycle
- Oxacycle
- Carboxylic acid derivative
- Alcohol
- Organonitrogen compound
- Organic nitrogen compound
- Organooxygen compound
- Amine
- Carbonyl group
- Primary amine
- Organic oxygen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Organic oxide
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. | 7.0 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 29.2271 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.92 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 5484.2 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 183.3 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 338.4 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 222.8 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 957.9 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 1703.4 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 1138.5 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 321.6 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 3046.2 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 1330.1 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 2641.1 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 1170.8 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 703.8 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 250.5 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 312.9 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 11.9 seconds | 40023050 |
Predicted Kovats Retention IndicesNot Available |
|---|
| MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(20:3(8Z,11Z,14Z)/20:3(5Z,8Z,11Z)) 10V, Positive-QTOF | splash10-03di-1910000100-0c516cd7b01465db63b5 | 2019-02-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(20:3(8Z,11Z,14Z)/20:3(5Z,8Z,11Z)) 20V, Positive-QTOF | splash10-03di-2910000100-6841bff7ac37d4540200 | 2019-02-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(20:3(8Z,11Z,14Z)/20:3(5Z,8Z,11Z)) 40V, Positive-QTOF | splash10-03di-3911001010-6b60ed0d7cbc168bf214 | 2019-02-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(20:3(8Z,11Z,14Z)/20:3(5Z,8Z,11Z)) 10V, Negative-QTOF | splash10-0a4i-5945000310-15c58fde194af9bf7460 | 2019-02-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(20:3(8Z,11Z,14Z)/20:3(5Z,8Z,11Z)) 20V, Negative-QTOF | splash10-0bt9-9848120130-7935722879fd72eea2c4 | 2019-02-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(20:3(8Z,11Z,14Z)/20:3(5Z,8Z,11Z)) 40V, Negative-QTOF | splash10-0a4i-4902000000-a77ebbed1987358aa54e | 2019-02-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(20:3(8Z,11Z,14Z)/20:3(5Z,8Z,11Z)) 10V, Positive-QTOF | splash10-0udi-9000000013-76f66ee9892fe843a2ec | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(20:3(8Z,11Z,14Z)/20:3(5Z,8Z,11Z)) 20V, Positive-QTOF | splash10-0230-3000000009-e57a76cd27a4221705e0 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(20:3(8Z,11Z,14Z)/20:3(5Z,8Z,11Z)) 40V, Positive-QTOF | splash10-006t-0077900011-d68bd3e02a1686aebb85 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(20:3(8Z,11Z,14Z)/20:3(5Z,8Z,11Z)) 10V, Negative-QTOF | splash10-0udi-9000000200-f293557a0819f5af400a | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(20:3(8Z,11Z,14Z)/20:3(5Z,8Z,11Z)) 20V, Negative-QTOF | splash10-054o-9033810420-e18bebfdf71855d082ab | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(20:3(8Z,11Z,14Z)/20:3(5Z,8Z,11Z)) 40V, Negative-QTOF | splash10-0a59-8319320400-934b9391f9037a8e908d | 2021-09-22 | Wishart Lab | View Spectrum |
|
|---|